BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2044580)

  • 1. Copper and liver disease.
    Danks DM
    Eur J Pediatr; 1991 Jan; 150(3):142-8. PubMed ID: 2044580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition, diagnosis, and management of Wilson's disease.
    Brewer GJ
    Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilson disease.
    El-Youssef M
    Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutic approaches to the treatment of Wilson's disease.
    Brewer GJ
    Expert Opin Pharmacother; 2006 Feb; 7(3):317-24. PubMed ID: 16448326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilson disease - currently used anticopper therapy.
    Członkowska A; Litwin T
    Handb Clin Neurol; 2017; 142():181-191. PubMed ID: 28433101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Wilsons disease].
    Mareček Z; Brůha R
    Vnitr Lek; 2013 Jul; 59(7):578-83. PubMed ID: 23909262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilson disease--a practical approach to diagnosis, treatment and follow-up.
    Medici V; Rossaro L; Sturniolo GC
    Dig Liver Dis; 2007 Jul; 39(7):601-9. PubMed ID: 17382611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
    Brewer GJ
    CNS Drugs; 2005; 19(3):185-92. PubMed ID: 15740174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
    Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
    Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilson disease: genetic basis of copper toxicity and natural history.
    Schilsky ML
    Semin Liver Dis; 1996 Feb; 16(1):83-95. PubMed ID: 8723326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
    Appenzeller-Herzog C; Mathes T; Heeres MLS; Weiss KH; Houwen RHJ; Ewald H
    Liver Int; 2019 Nov; 39(11):2136-2152. PubMed ID: 31206982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of Wilson disease].
    Smolarek C; Stremmel W
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wilson's disease and its pharmacological treatment].
    Hayashi H; Suzuki R; Wakusawa S
    Yakugaku Zasshi; 2004 Nov; 124(11):711-24. PubMed ID: 15516801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
    Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
    J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
    Schilsky M
    Hepatology; 2009 Nov; 50(5):1341-3. PubMed ID: 19877301
    [No Abstract]   [Full Text] [Related]  

  • 18. Wilson's Disease: A Review for the General Pediatrician.
    Capone K; Azzam RK
    Pediatr Ann; 2018 Nov; 47(11):e440-e444. PubMed ID: 30423186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
    Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
    Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.